Accustem Sciences Inc. (ACUT)
OTC Markets
Key stats Fiscal year 2025
Income statement
- Net income
- -1,756,096
- Operating income
- -1,756,096
- Earnings per share
- -0.12
- R&D expense
- 281,014
Growth and profitability
- Return on assets
- -113.34
Balance sheet
- Total assets
- 1,549,446
- Total liabilities
- 4,951,071
- Shareholders' equity
- -3,401,625
- Current ratio
- 0.01
Cash flow and ratios
- Operating cash flow
- -850,389
Shareholder returns
- Shares outstanding
- 16,072,267
Company information
- Headquarters
- New York, NY
- Exchange
- OTC Markets
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
Accustem Sciences Inc. trades on OTC Markets under the ticker symbol ACUT. This page brings together its price chart, company profile, key financial figures and technical indicators.